论文部分内容阅读
下肢深静脉血栓又称为LDVT,在这种病症下,我们可以通过检查病患身体中的蛋白C,抗凝血酶等元素来进行研究和治疗,治疗的过程是非常复杂的,需要注意多个元素的含量对比,然后进行相应的判断[1]。我们在医学上对于这种病症也采取了很多的探索手段,笔者也不例外,本文主要是通过来研究这些含量的变化并且与LDVT来相联系,希望能够给医学上提供一些新的思路。在研究过程中,我们会用到一种叫全自动血凝仪的一起,这种仪器来源于法国的一家公司,通过这项仪器我们可以来测定选中患者的蛋白C,蛋白S,D—D值,AT-III等参数。而我们测定的方法是希望能够通过对比患者在治疗前和被治疗后身体内所存在的这几项参数的变化情况[2]。我们在测量之后,发现测试组所反映出来的蛋白C含量是远远低于我们的参照组的,当然在统计学测试过程中我们的P是大于0.05的。通过具体过程的分析,我们可以了解到,蛋白C和蛋白S对于LDVT的形成有着密切的联系,而测试中所得到的AT-III事实上与我们研究的病症并无很大的关联。因此在我们的探索过程中,我们需要重视蛋白C和蛋白S的参数变化情况,并且针对性的对这两项参数进行治疗,相信对于促进和优化LDVT的治疗方案会有很积极的作用,并且可以提高临床的成功率[3]。
Lower extremity deep venous thrombosis, also known as LDVT, in which we can study and treat by examining the body of patients with protein C, antithrombin and other elements, the treatment process is very complex and need to pay attention to more A comparison of the content of the elements, and then make the appropriate judgment [1]. We have also taken a lot of explorations on this condition in medicine, and the author is no exception. This paper mainly studies the changes of these contents and links with LDVT, hoping to provide some new ideas in medicine. In the course of the study, we will use a device called automatic coagulation analyzer, a device from a French company, we can use this instrument to determine the selection of patients with protein C, protein S, D-D Value, AT-III and other parameters. Our method of determination is to compare the changes of these parameters in the body before and after treatment [2]. After the measurement, we found that the test group reflects the protein C content is far lower than our reference group, of course, in the statistical test our P is greater than 0.05. Through the analysis of the specific process, we can see that protein C and protein S are closely related to the formation of LDVT, and the AT-III obtained in the test is in fact not significantly associated with the disorder we studied. Therefore, in our exploration process, we need to pay attention to the parameters of protein C and protein S changes, and the targeted treatment of these two parameters, I believe that for the promotion and optimization of LDVT treatment programs will have a very positive effect, and Can improve the clinical success rate [3].